BuChE K variant is decreased in Alzheimer's disease not in fronto-temporal dementia

被引:15
|
作者
Bizzarro, Alessandra [1 ]
Guglielmi, V. [1 ]
Lomastro, R. [3 ]
Valenza, A. [4 ]
Lauria, A. [1 ]
Marra, C. [1 ]
Silveri, M. C. [2 ]
Tiziano, F. D. [3 ]
Brahe, C. [3 ]
Masullo, C. [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Inst Neurol, I-00168 Rome, Italy
[2] Catholic Univ, Dept Geriatr, I-00168 Rome, Italy
[3] Catholic Univ, Inst Med Genet, I-00168 Rome, Italy
[4] Osped Belcolle, Neurol Unit, Viterbo, Italy
关键词
BuChE K variant polymorphism; Alzheimer's disease; Fronto-temporal dementia; APOE; Risk factors; Cholinergic system; Therapy; BUTYRYLCHOLINESTERASE GENE; APOLIPOPROTEIN E4; NO ASSOCIATION; EPSILON-4; ALLELE; APOE EPSILON-4; ONSET; AGE; ACETYLCHOLINESTERASE; POLYMORPHISMS; GENOTYPE;
D O I
10.1007/s00702-009-0358-y
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Alzheimer's disease (AD) is characterized by a significant reduction in AcetylCholinesterase and an increase in ButyrylCholinesterase (BuChE) activity. The existence of polymorphic regions on the BuChE gene has been previously described; the most frequently found polymorphism is the so-called K variant, which leads to a 30% decreased enzymatic activity. Different studies reported a positive association between K variant and AD, strongest among late-onset AD and Apolipoprotein E (APOE) e4 carriers. We analyzed APOE and BuChE polymorphisms in 167 AD and 59 fronto-temporal dementia (FTD) patients compared with 129 healthy controls (HC). We reported a significantly lower frequency of the BuChE K variant in AD compared with HC and FTD and a significant increased frequency of the K variant in FTD. These results are in agreement with the known increase of the BuChE activity in AD and support the evidence of different molecular pathways involved in the pathogenesis of AD and FTD.
引用
收藏
页码:377 / 383
页数:7
相关论文
共 50 条
  • [31] Closing-in behaviour in fronto-temporal dementia
    Ambron, Elisabetta
    Allaria, Francesca
    McIntosh, Robert D.
    Della Sala, Sergio
    JOURNAL OF NEUROLOGY, 2009, 256 (06) : 1004 - 1006
  • [32] Pharmacotherapy for BPSD in fronto-temporal dementia in Japan
    Ikeda, Manabu
    INTERNATIONAL PSYCHOGERIATRICS, 2011, 23 : S91 - S92
  • [33] Towards fronto-temporal dementia early diagnosis
    Arizaga, RL
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 12 - 12
  • [34] IMPAIRMENT OF SOCIAL COGNITION IN FRONTO-TEMPORAL DEMENTIA
    Serrani, Daniel
    PSIENCIA-REVISTA LATINOAMERICANA DE CIENCIA PSICOLOGICA, 2013, 5 (02): : 90 - 104
  • [35] Spectrum of clinical aspects in Fronto-Temporal Dementia
    vanSwieten, J
    Stevens, M
    Ravid, R
    Kamphorst, W
    vanGool, P
    Scheltens, P
    vanDuijn, CM
    NEUROLOGY, 1997, 48 (03) : 5029 - 5029
  • [36] Do not confuse depression with fronto-temporal dementia
    Alario Ruiz, C.
    Fernandez Rodriguez, C.
    Herrera Gener, P.
    Royuela Rico, A.
    Pascual Alonso, A.
    EUROPEAN PSYCHIATRY, 2019, 56 : S426 - S426
  • [37] Subjective clustering in patients with fronto-temporal dementia
    Perri, Roberta
    Fadda, Lucia
    Caltagirone, Carlo
    Carlesimo, Giovanni A.
    APPLIED NEUROPSYCHOLOGY-ADULT, 2024, 31 (02) : 144 - 154
  • [38] Symptomatology and pharmacological treatment of Fronto-temporal dementia
    Ikeda, Manabu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 33P - 33P
  • [39] Fronto-temporal dementia: Nosology, neuropsychology, and neuropathology
    Neary, D
    Snowden, J
    BRAIN AND COGNITION, 1996, 31 (02) : 176 - 187
  • [40] Saccade impairments in patients with fronto-temporal dementia
    Meyniel, C
    Rivaud-Péchoux, S
    Damier, P
    Gaymard, B
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (11): : 1581 - 1584